NORA HADLOCK: Open Payments
NPI 1346989811 · WHITESBORO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 9 payments from 7 companies in 2025. Trend: 2023 $108 · 2024 $77 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $54 |
| Astellas Pharma US Inc | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Organon LLC | 1 | $16 |
Products named: ZURZUVAE, Veozah, Lynkuet, MYFEMBREE, Exparel, ACCRUFER, NEXPLANON.
Industry payments across NY — which companies pay providers there.
